SE408419B - Sett att framstella morfolinderivat - Google Patents

Sett att framstella morfolinderivat

Info

Publication number
SE408419B
SE408419B SE7605248A SE7605248A SE408419B SE 408419 B SE408419 B SE 408419B SE 7605248 A SE7605248 A SE 7605248A SE 7605248 A SE7605248 A SE 7605248A SE 408419 B SE408419 B SE 408419B
Authority
SE
Sweden
Prior art keywords
way
morpholine derivatives
produce
produce morpholine
derivatives
Prior art date
Application number
SE7605248A
Other languages
English (en)
Swedish (sv)
Other versions
SE7605248L (sv
Inventor
S A Lee
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB5013069A external-priority patent/GB1260886A/en
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of SE7605248L publication Critical patent/SE7605248L/sv
Publication of SE408419B publication Critical patent/SE408419B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
SE7605248A 1969-10-13 1976-05-07 Sett att framstella morfolinderivat SE408419B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5013069A GB1260886A (en) 1969-06-20 1969-06-20 Process for aryloxymethylmorpholine derivatives

Publications (2)

Publication Number Publication Date
SE7605248L SE7605248L (sv) 1976-05-07
SE408419B true SE408419B (sv) 1979-06-11

Family

ID=10454773

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7605248A SE408419B (sv) 1969-10-13 1976-05-07 Sett att framstella morfolinderivat

Country Status (5)

Country Link
CS (1) CS167901B2 (enrdf_load_html_response)
DK (1) DK143399C (enrdf_load_html_response)
PL (1) PL88898B1 (enrdf_load_html_response)
SE (1) SE408419B (enrdf_load_html_response)
SU (1) SU382287A3 (enrdf_load_html_response)

Also Published As

Publication number Publication date
SE7605248L (sv) 1976-05-07
PL88898B1 (enrdf_load_html_response) 1976-10-30
SU382287A3 (enrdf_load_html_response) 1973-05-22
DK143399B (da) 1981-08-17
CS167901B2 (enrdf_load_html_response) 1976-05-28
DK143399C (da) 1981-12-21

Similar Documents

Publication Publication Date Title
SE383159B (sv) Sett att framstella vesikuler polymer
SE393377B (sv) Sett att framstella morfolinderivat
SE412586B (sv) Sett att framstella isoflavonderivat
SE385701B (sv) Sett att framstella 1,4-bensodiazepinderivat
SE385889B (sv) Sett att framstella morfolinderivat
SE421690B (sv) Sett att framstella bifunktionellt tverbundna insulinderivat
SE382215B (sv) Sett att framstella kromanderivat
SE391181B (sv) Sett att framstella kinazolinderivat
SE387337B (sv) Sett att framstella nya tiokarbamidsyraderivat
SE399255B (sv) Sett att framstella kinazolinonderivat
SE7603276L (sv) Sett att framstella prostansyraderivat
SE417211B (sv) Sett att framstella indenyl-3-acetoglucuronider
SE417981B (sv) Sett att framstella cefalosporinforeningar
SE381257B (sv) Sett att framstella rifamycinderivat
SE420087B (sv) Sett att framstella bifunktionellt tverbundna insulinderivat
SE400078B (sv) Sett att framstella kinazolinonderivat
SE405966B (sv) Sett att framstella peptider
SE397679B (sv) Sett att framstella kinazolinonderivat
SE400281B (sv) Sett att framstella kinazolinonderivat
SE401184B (sv) Sett att framstella morfolinderivat
SE399712B (sv) Sett att framstella pregnansyraderivat
SE419647B (sv) Sett att framstella tiazolisokinolinderivat
SE390301B (sv) Sett att framstella butyrfenonederivat
SE387632B (sv) Sett att framstella nya 3-amino-delta?722-pyrazolinderivat
SE417830B (sv) Sett att framstella vissa sulfonylmetylsubstituerade bicykloalkanoner

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7605248-9

Effective date: 19901019

Format of ref document f/p: F